Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/bmjspcare-2020-002718 | DOI Listing |
Int J Womens Health
December 2024
Nursing Department, Electric Power Hospital, Beijing, 100073, People's Republic of China.
To summarise the therapeutic effects of symptomatic nursing during DS-8201 (Enhertu) treatment in a patient with advanced breast cancer with metastases to the ribs, lungs and liver. The patient, diagnosed with breast cancer with multiple metastases, was admitted to the hospital on 4 January 2021, 2 months after the discovery of a right breast mass. DS-8201 was administered during this period, and nursing care was tailored to address the patient's symptoms while on the medication.
View Article and Find Full Text PDFIntegr Cancer Ther
December 2024
School of Nursing, China Medical University, Taichung, Taiwan.
Int J Nurs Stud
December 2024
School of Nursing, Inha University, Incheon, South Korea. Electronic address:
Background: Cancer survivors may have a variety of survivorship concerns despite their cancer treatment having ended, with some negatively affecting their health-related quality of life. An in-depth understanding of survivorship concerns is essential for the development of survivorship care programs. However, previous findings have been limited to Western countries, and evidence from Asian countries is lacking.
View Article and Find Full Text PDFPsychooncology
December 2024
Department of Psychiatry & Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, USA.
Taste disturbances are prominent side effects of antineoplastic medications and contribute to morbidity and quality-of-life impairment. Few treatment options are available for antineoplastic-related taste disorders. Hypnosis has been found to be effective for a variety of symptoms in the cancer setting, including insomnia, pain, mood disorders and anxiety.
View Article and Find Full Text PDFCureus
November 2024
Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA.
Hypercalcemia is a common metabolic complication associated with malignancies, particularly in solid tumors, such as lung and breast cancers. However, its occurrence in hematologic malignancies, including diffuse large B-cell lymphoma (DLBCL), is rare. The pathophysiology of hypercalcemia in lymphomas is often related to the secretion of parathyroid hormone (PTH)-related peptide (PTHrP).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!